#Tirzepatide

Tirzepatide is a new class of medication for #t2d that activates GIP and #glp1 receptors. #Endocrinologist Dr. Thomas Blevins (MD, FACE) from #Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for #clinicians
#diabetestreatment #diabetes #diabetes #diabetologist #endocrinology #glp1 #antidiabetic #t2dm
Our Social Media:
Facebook: / cardiovisual
Twitter: / cardiovisualapp
LinkedIn: / cardiovisual
Instagram: / cardiovisual
---------------------------------------------------------------------------------------------
For more information & latest articles on heart health visit: cardiovisual.com/